Invivyd Inc (IVVD)
2.40
-0.05
(-2.04%)
USD |
NASDAQ |
May 17, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Invivyd Cash and Short Term Investments (Quarterly): 189.39M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 189.39M |
| December 31, 2023 | 200.64M |
| September 30, 2023 | 264.88M |
| June 30, 2023 | 298.43M |
| March 31, 2023 | 333.43M |
| December 31, 2022 | 371.99M |
| September 30, 2022 | 418.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 474.88M |
| March 31, 2022 | 532.22M |
| December 31, 2021 | 591.42M |
| September 30, 2021 | 666.32M |
| June 30, 2021 | 392.51M |
| March 31, 2021 | 91.25M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
91.25M
Minimum
Mar 2021
666.32M
Maximum
Sep 2021
371.23M
Average
371.99M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 394.14M |
| Viking Therapeutics Inc | 962.98M |
| Stoke Therapeutics Inc | 178.58M |
| 180 Life Sciences Corp | 1.976M |
| MAIA Biotechnology Inc | 8.271M |